Trump Strikes Deals with Nine Drug Companies to Lower Prescription Prices

Nine drug companies agreed to lower prices on Dec 19, 2025, with a new website TrumpRx. Find out how this affects prescription costs for Americans.

#DrugPrices, #TrumpDeals, #HealthcareCosts, #PharmaNews, #USManufacturing

https://newsletter.tf/trump-drug-deals-december-19-2025-lower-prices-americans/

Nine drug companies agreed to lower prices on prescription drugs starting in January 2026. This is a change from previous pricing structures.

#DrugPrices, #TrumpDeals, #HealthcareCosts, #PharmaNews, #USManufacturing

https://newsletter.tf/trump-drug-deals-december-19-2025-lower-prices-americans/

Trump drug deals on Dec 19, 2025, promise lower prices for Americans

Nine drug companies agreed to lower prices on Dec 19, 2025, with a new website TrumpRx. Find out how this affects prescription costs for Americans.

Big Pharma’s Hidden Power Shift: DHL Expands Global Drug Delivery Empire

Global logistics giant DHL is expanding its pharmaceutical airfreight network — and this isn’t just about faster shipping.

Behind the move is a trillion-dollar power play to control how medicines travel worldwide. From vaccines to biotech drugs, whoever dominates pharma logistics gains massive influence over global healthcare supply chains.

#DHL #pharmanews

ENTOD Pharmaceuticals Joins Global Efforts to Tackle Preventable Childhood Blindness – Tycoon World

New Delhi, 12th February, 2026: ENTOD Pharmaceuticals, a global ophthalmology-focused pharmaceutical company, reaffirmed its commitment to preventing

Tycoon World
CDSCO flags 167 drug samples as Not of Standard Quality (NSQ) in December, including spurious drugs. Learn about the latest drug safety alerts and regulatory actions. https://english.mathrubhumi.com/news/india/cdsco-drug-quality-alert-december-h3iajdl6?utm_source=dlvr.it&utm_medium=mastodon #CDSCO #DrugSafety #NSQDrugs #MedicineQuality #PharmaNews

New lawsuits claim Ozempic and other GLP-1 drugs may be linked to NAION-related vision loss. Patients allege unexpected blindness risks. Read More Here: https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/
#Ozempic #GLP1 #NAION #VisionLoss #DrugSafety #PharmaNews

https://www.jdsupra.com/legalnews/ozempic-blindness-lawsuits-legal-claims-1081107/

Ozempic Blindness Lawsuits: Legal Claims Allege GLP-1 Drugs Linked to NAION Vision Loss | JD Supra

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight...

JD Supra
Latest Hindi News : कोल्ड्रिफ कांड : स्रसेन फार्मा के डायरेक्टर रंगनाथन गिरफ्तार, जांच तेज

एक फार्मास्युटिकल कंपनी स्रसेन फार्मा की ओर से निर्मित जहरीले कोल्ड्रिफ कफ सीरप ने मध्य प्रदेश में कम से कम 20 बच्चों की जान ले ली।

Hindi Vaartha
Pfizer CEO praises Trump administration amid ongoing pharma industry shifts, while RFK Jr. pushes for major CDC reforms. Meanwhile, Novartis seals a massive $5.2 billion deal, shaking up global healthcare markets. Big moves in pharma today! 💊🌍 #PharmaNews #HealthInnovation
Time to End Roundtripping by Big Pharma

U.S. pharma companies should pay rather more of their corporate income tax in the U.S.—and start producing more of their best drugs in the U.S. as well.

Council on Foreign Relations

Lilly’s stock fell over 14% after new test results showed their weight loss pill helped users lose less weight than expected. Side effects like nausea also concerned investors. Despite strong sales from other drugs, the future in the weight loss market looks challenging.

#Lilly #WeightLoss #StockMarket #PharmaNews